Biolipox Overview

  • Founded
  • 2000
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 9
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $135M
Latest Deal Amount

Biolipox General Information

Description

Provider of drugs for inflammatory diseases. The company is focused on therapies for inflammatory diseases including pain management and respiratory diseases like asthma and chronic obstructive pulmonary disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Berzelius väg 3
  • plan 5
  • 171 65 Solna
  • Sweden
+46 08-524 000 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biolipox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 23-Nov-2007 $135M 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series C) 10-Oct-2005 0000 000.00 Completed Startup
3. Grant 26-Feb-2005 000.00 Completed Startup
2. Early Stage VC (Series B) 22-Jan-2003 $22.1M $26.5M Completed Startup
1. Early Stage VC (Series A) 01-Mar-2001 $4.43M $4.43M Completed Startup
To view Biolipox’s complete valuation and funding history, request access »

Biolipox Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biolipox Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Apax Partners PE/Buyout Minority 000 0000 000000 0
Auriga Partners (Paris) Venture Capital Minority 000 0000 000000 0
Credit Lyonnais Private Equity PE/Buyout Minority 000 0000 000000 0
HealthCap Venture Capital Minority 000 0000 000000 0
Scandinavian Life Science Venture Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Biolipox Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 19-Nov-2007 000000000 00000 00 0000 Buildings and Property 00000ö00 000000 00
To view Biolipox’s complete investments history, request access »